Atomo Diagnostics Limited (ASX:AT1) Announces National Scale-Up and NZ Launch
Atomo Diagnostics (ASX:AT1) scales national HIV self-test program in Australia and expands into New Zealand through Chemist Warehouse.
Tag: Industry-Specific News
Elixir Energy (ASX:EXR) Farms Out Diona Sub-block to Xstate Resources
Elixir Energy (ASX:EXR) farms out the Diona sub-block to Xstate Resources, securing operational expansions and future exploration plans.
Native Mineral Resources (ASX:NMR) Receives Second Instalment from Wes Maas to Advance Gold Production
Native Mineral Resources (ASX:NMR) secures a second $2.26M instalment from Wes Maas to advance gold production in Queensland, targeting Q3 2025 for first gold pour.
Alkane Resources Ltd (ASX:ALK) Announces March FY2025 Quarter Results
Alkane Resources (ASX:ALK) reports increased cash and bullion for March FY2025 quarter, maintaining guidance and highlighting strong operational performance.
Contact Energy (ASX:CEN) Releases March 2025 Operating Report
Contact Energy (ASX:CEN) releases its March 2025 operating report, highlighting increased netback, sales volumes, and progress on key projects.
Structural Monitoring Systems PLC (ASX:SMN) Updates on US Tariffs Impact
Structural Monitoring Systems PLC (ASX:SMN) announces an update on US reciprocal tariffs, confirming tariff-free status for its compliant avionics products and ongoing monitoring of trade impacts.
Ansell Limited (ASX:ANN) Announces US Tariffs Update
Ansell Limited (ASX:ANN) addresses new US tariffs, maintains FY25 EPS guidance despite sourcing and pricing challenges.
Mesoblast (ASX:MSB) Announces U.S. Tariff Exemption for Allogeneic Cell Therapies
Mesoblast (ASX:MSB) announces its allogeneic cell therapies are exempt from U.S. tariffs as ‘U.S. Country of Origin’ products.
Orthocell Limited (ASX:OCC) Receives FDA Clearance for Remplir™
Orthocell (ASX:OCC) secures FDA clearance for Remplir™, enabling entry into the US $1.6 billion nerve repair market.
Australian Rare Earths Limited (ASX:AR3) Confirms Uranium Intersections
Australian Rare Earths Limited (ASX:AR3) confirms uranium intersections in OV047, highlighting significant mineralisation potential and ongoing drilling efforts.